Prospective comparison of CT- and MRI-based tumor delineation based on intraoperative navigation and spatially annotated pathology in locally advanced midfacial squamous cell carcinoma

Introduction Precise tumor delineation is critical for navigation-guided surgery and radiotherapy (RT) in locally advanced midfacial squamous cell carcinoma (SCC). Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are both recommended for staging and provide complementary information. However, quantitative comparisons of CT- and MRI-based tumor contours remain scarce, while a spatial comparison with histopathological data has never been performed. Therefore, we prospectively compared gross tumor volumes (GTV) derived from CT and MRI before navigation-guided surgery and correlated the results with spatially annotated pathology. Methods This imaging sub-analysis was conducted within the prospective NAVIGATORR trial (NCT05671458). Fifteen patients with locally advanced midfacial SCC underwent contrast-enhanced CT and 1.5T or 3T MRI (T1w, T2w, DWI) for navigation-based surgery planning. Datasets were rigidly co-registered and an experienced radiologist independently contoured the GTV on CT and MRI while blinded to the other modality. Besides qualitative and volumetric evaluation, spatial agreement was assessed using the Dice similarity coefficient (DSC) and Hausdorff distance (HD). Tumor contours were correlated with spatially annotated intraoperative biopsy locations and histopathological results. Results Fifteen patients and 109 spatially annotated biopsy locations (19 tumor-positive) were analyzed. MRI was preferred for tumor delineation by the radiologist in all cases, with superior differentiation between tumor and mucosal swelling (73%) and improved soft tissue contrast (67%). MRI based GTVs were significantly larger than CT-based GTVs (median 28.3 ml vs. 16.8 ml; p = 0.02). DSC values demonstrated fair agreement with considerable heterogeneity (median 0.58; IQR 0.47-0.65), and median HD was 16 mm (IQR 12–27 mm). MRI-based contours encompassed numerically more tumor-positive biopsy locations than CT-based contours (6/19 vs. 1/19; clustered McNemar p = 0.20) while including fewer tumor-negative locations (7/90 vs. 10/90; p = 0.53). At patient level, at least one tumor-positive biopsy was located inside the contour in 3/8 (MRI) vs. 1/8 (CT) patients. Discussion GTV delineation differs substantially between MRI and CT in locally advanced midfacial SCC, and the two modalities provide complementary information. These exploratory findings support the complementary use of MRI and CT for tumor visualization. Clinical implications remain to be shown by the primary endpoint analysis of the NAVIGATORR trial.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-06
DOI
https://doi.org/10.3389/fonc.2026.1884392
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prospective comparison of CT- and MRI-based tumor delineation based on intraoperative navigation and spatially annotated pathology in locally advanced midfacial squamous cell carcinoma

Maximilian Y. Deng, Sebastian Regnery, Philipp Schröter, Thomas Welzel et al.
1 links
Frontiers in Oncology
Head and Neck Cancer Studies
article

Prospective comparison of CT- and MRI-based tumor delineation based on intraoperative navigation and spatially annotated pathology in locally advanced midfacial squamous cell carcinoma

Maximilian Y. Deng, Sebastian Regnery, Philipp Schröter, Thomas Welzel, Jürgen Hoffmann, Lukas Bauer, Julius Moratin, Sebastian Adeberg, Florian Stritzke, Jennifer C. Fuchs, Markus Ehle, Anja Sander, Reinald Kühle, Jürgen Debus, Katharina Kozyra, Rasmus Schindehütte, Thomas Held
article en

Abstract

Introduction Precise tumor delineation is critical for navigation-guided surgery and radiotherapy (RT) in locally advanced midfacial squamous cell carcinoma (SCC). Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are both recommended for staging and provide complementary information. However, quantitative comparisons of CT- and MRI-based tumor contours remain scarce, while a spatial comparison with histopathological data has never been performed. Therefore, we prospectively compared gross tumor volumes (GTV) derived from CT and MRI before navigation-guided surgery and correlated the results with spatially annotated pathology. Methods This imaging sub-analysis was conducted within the prospective NAVIGATORR trial (NCT05671458). Fifteen patients with locally advanced midfacial SCC underwent contrast-enhanced CT and 1.5T or 3T MRI (T1w, T2w, DWI) for navigation-based surgery planning. Datasets were rigidly co-registered and an experienced radiologist independently contoured the GTV on CT and MRI while blinded to the other modality. Besides qualitative and volumetric evaluation, spatial agreement was assessed using the Dice similarity coefficient (DSC) and Hausdorff distance (HD). Tumor contours were correlated with spatially annotated intraoperative biopsy locations and histopathological results. Results Fifteen patients and 109 spatially annotated biopsy locations (19 tumor-positive) were analyzed. MRI was preferred for tumor delineation by the radiologist in all cases, with superior differentiation between tumor and mucosal swelling (73%) and improved soft tissue contrast (67%). MRI based GTVs were significantly larger than CT-based GTVs (median 28.3 ml vs. 16.8 ml; p = 0.02). DSC values demonstrated fair agreement with considerable heterogeneity (median 0.58; IQR 0.47-0.65), and median HD was 16 mm (IQR 12–27 mm). MRI-based contours encompassed numerically more tumor-positive biopsy locations than CT-based contours (6/19 vs. 1/19; clustered McNemar p = 0.20) while including fewer tumor-negative locations (7/90 vs. 10/90; p = 0.53). At patient level, at least one tumor-positive biopsy was located inside the contour in 3/8 (MRI) vs. 1/8 (CT) patients. Discussion GTV delineation differs substantially between MRI and CT in locally advanced midfacial SCC, and the two modalities provide complementary information. These exploratory findings support the complementary use of MRI and CT for tumor visualization. Clinical implications remain to be shown by the primary endpoint analysis of the NAVIGATORR trial.

Frontiers in OncologyVol. 16
Heidelberg University (DE), Universitätsklinikum Gießen und Marburg (DE), University Hospital Heidelberg (DE), Heidelberger Institut für Radioonkologie (DE), National Center for Tumor Diseases (DE)
Nationales Centrum für Tumorerkrankungen Heidelberg, Medizinischen Fakultät Heidelberg, Universität Heidelberg
Good health and well-being
Openalex Percentile: Top 11%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon